Rapilif (Rapaflo)4 Mg – 100 tablet


Each Rapilif contains 4 mg Silodosin 100 tablets. Used to treat the signs and symptoms of benign prostatic hyperplasia (prostate enlargement).

Active Ingrediant: Silodosin
Generic Name: Rapilif
Manufacturer: IPCA Lab Ltd
Strength: 4 Mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 Tabs

Inquire Us

Medication Safety Issues

Sound-alike/look-alike issues:

Rapaflo may be confused with Rapamune
Silodosin may be confused with sildenafil, sirolimus


Store at room temperature of 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light. Protect from moisture.

Adverse Reactions

>10%: Genitourinary: Retrograde ejaculation (28%)

1% to 10%:

Cardiovascular: Orthostatic hypotension (3%; increased in elderly ≥65 years up to 5%)
Central nervous system: Dizziness (3%), headache (2%), insomnia (1% to 2%)
Gastrointestinal: Diarrhea (3%), abdominal pain (1% to 2%)
Genitourinary: Prostate specific antigen increased (1% to 2%)
Neuromuscular & skeletal: Weakness (1% to 2%)
Respiratory: Nasal congestion (2%), rhinorrhea (1% to 2%), sinusitis (1% to 2%)

<1%, postmarketing, and/or case reports: Hepatic insufficiency, hypersensitivity reaction, increased serum transaminases, intraoperative floppy iris syndrome, jaundice, pharyngeal edema, priapism, pruritus, purpura, skin rash (including toxic), swollen tongue, syncope, urticaria